Header Artwork
Header Artwork

BLOG

The Case of the Vanishing Thickness: How NMR Solves the Impurity Mystery

Blog Post 8 – The Case of the Vanishing Thickness: How NMR Solves the Impurity Mystery

2 min reading time

In pharmaceutical manufacturing, even the smallest modifications to packaging can have significant consequences. In a recent project, a minor reduction in the thickness of the packaging led to the appearance of an unexpected impurity. Our investigation revealed that this alteration allowed a leachable component from the packaging system to migrate more readily, ultimately reacting with an ingredient in the drug product and generating a new impurity.

The impurity was initially detected by our client using liquid chromatography coupled with ultraviolet detection (LC/UV). The sponsor’s LC/UV method was then transferred to our high-end LC/MS platform, enabling high-resolution mass spectrometry-based characterization. From the LC/MS studies, we determined that the impurity was a reaction product arising from the interaction of a leachable compound and a constituent of the drug product. While LC/MS provided valuable insights into the molecular mass and fragmentation patterns—linking the impurity to two known compounds—it could not clarify how these compounds interacted to form the final product.

To address this gap, we worked together with our network to perform additional NMR experiments, including advanced techniques, like HSQC (Heteronuclear Single Quantum Coherence), HMBC (Heteronuclear Multiple Bond Correlation) spectroscopy and COSY (Homonuclear COrrelation SpectroscopY). NMR revealed the precise atomic connectivity and chemical environment within the molecule. This allowed us to pinpoint exactly how the reaction occurred at a structural level, information that LC/MS alone could not offer. Since we found out how the impurity could be synthesized, we were able to produce the impurity on a larger scale and therefore we could conduct detailed NMR experiments, ultimately confirming both its identity and the formation pathway.

Through our network of expert partners, we gain access to advanced analytical platforms such as NMR. At Nelson Labs, we apply a multidimensional strategy to impurity characterization — combining deep knowledge of potential leachables with techniques like LCMS, NMR, and others. This integrated approach allows us to detect, identify, and manage unexpected contaminants, supporting the highest standards in pharmaceutical quality control.

Figure 1: Overview of different steps for identification via the combination of LCMS and NMR

 

If you have additional questions about Impurities Identification test services or would like to consult with the experts at Nelson Labs, just send an e-mail to [email protected].

 

Julie Van Hooste

Scientific Expert

Julie Van Hooste earned her master’s degree in chemistry in 2020, with a specialization in analytical instrumental chemistry and organic chemistry. That same year, she joined Nelson Labs Europe as a Scientific Project Manager in the Extractables & Leachables department, where she contributed to the chemical safety assessment of medical devices and large volume parenterals. Since 2023, Julie has taken on the role of Scientific Project Manager for Structural Elucidation, focusing on the identification of unknown chemical compounds. Her work plays a critical role in uncovering the molecular structures behind complex analytical findings, supporting product safety and regulatory compliance through advanced spectroscopic techniques and expert interpretation.